Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,640 | Dovepress* | 8,019+ | 1,042 | 9,061 | |
PubMed Central* | 621 | 199 | 820 | ||
Totals | 8,640 | 1,241 | 9,881 | ||
*Since 5 March 2020 |
View citations on PubMed Central and Google Scholar